Generic placeholder image

Current Diabetes Reviews

Author(s): Cejana de Abrantes Figueiredo Baiocchi* and Diana Aristótelis Rocha de Sá

DOI: 10.2174/1573399817999201214224920

DownloadDownload PDF Flyer Cite As
Impact of Metabolic Surgery on Type-2 Diabetes Remission

Article ID: e121420189129 Pages: 11

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

Diabetes Mellitus is characterized by numerous metabolic disorders, which have in common the serum elevation of glucose, caused for a pancreatic malfunction in insulin secretion and / or its action. It is a non-communicable disease, considered major public health problems and generalized growth worldwide, being a chronic disease, which can generate a high treatment cost. Metabolic surgery is a safe treatment, regulated by the Federal Council of Medicine and useful in treating people with BMI over 30 years of age, who are unable to control pathologies associated with obesity, primarily type 2 diabetes. The general objective of this study is to understand through a literature review the main impacts of metabolic surgery about the remission of DM 2. This present study it is an exploratory and descriptive study carried out through a literature review. Data were collected through research in virtual health databases, at the Virtual Health Library - VHL, Latin American and Caribbean Health Sciences Information System, LILACS, National Library of Medicine - MEDLINE, Scielo, USP database, PUBMED theses and books. Metabolic surgery proof be a good and effective treatment for having and maintaining good weight loss, as well as a significant clinical and metabolic improvement that extends beyond weight loss. Metabolic surgery is a satisfactory way of achieving long-term weight reduction in obese individuals, increasing survival for these patients. Obese patients with DM2 have a long-term remission of DM2 after bariatric / metabolic surgery. Therefore, it concludes that such procedure is effective in the treatment of the disease and other diseases associated with obesity.

Keywords: Diabetes mellitus, bariatric surgery, metabolic surgery, remission, treatment, chronic disease.

[1]
Bray GA, Kim KK, Wilding JPH. World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev 2017; 18(7): 715-23.
[http://dx.doi.org/10.1111/obr.12551] [PMID: 28489290]
[2]
Courcoulas AP, Belle SH, Neiberg RH, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg 2015; 150(10): 931-40.
[http://dx.doi.org/10.1001/jamasurg.2015.1534] [PMID: 26132586]
[3]
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37(Suppl. 1): S81-90.
[http://dx.doi.org/10.2337/dc14-S081] [PMID: 24357215]
[4]
Villarejo C, Fernández-Aranda F, Jiménez-Murcia S, et al. Lifetime obesity in patients with eating disorders: increasing prevalence, clinical and personality correlates. Eur Eat Disord Rev 2012; 20(3): 250-4.
[http://dx.doi.org/10.1002/erv.2166] [PMID: 22383308]
[5]
Duncan BB, et al. The burden of diabetes and hyperglycemia in Brazil and its states: findings from the Global Burden of Disease Study 2015. Rev Bras Epidemiol, São Paulo 2017; 20(1): 90-101.
[6]
American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care 2012; 35(Suppl. 1): S11-63.
[http://dx.doi.org/10.2337/dc12-s011] [PMID: 22187469]
[7]
Brazilian Diabetes Society. Brazilian Diabetes Society 2019-2020 Guidelines / Organization José Egídio Paulo de Oliveira, Renan Magalhães Montenegro Junior, Sérgio Vencio. São Paulo: Editora Clannad 2019.
[8]
Cummings DE, Arterburn DE, Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia 2016; 59(5): 945-53.
[http://dx.doi.org/10.1007/s00125-016-3903-x] [PMID: 26983924]
[9]
Schauer PR, Bhatt DL, Kirwan JP, et al. STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes-5-year outcomes. N Engl J Med 2017; 376(7): 641-51.
[http://dx.doi.org/10.1056/NEJMoa1600869] [PMID: 28199805]
[10]
Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 2014; 311(22): 2297-304.
[http://dx.doi.org/10.1001/jama.2014.5988] [PMID: 24915261]
[11]
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366(17): 1577-85.
[http://dx.doi.org/10.1056/NEJMoa1200111] [PMID: 22449317]
[12]
Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C. Endocrine Society. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010; 95(11): 4823-43.
[http://dx.doi.org/10.1210/jc.2009-2128] [PMID: 21051578]
[13]
Rubino F, Nathan DM, Eckel RH, et al. Delegates of the 2nd Diabetes Surgery Summit. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by International Diabetes Organizations. Obes Surg 2017; 27(1): 2-21.
[http://dx.doi.org/10.1007/s11695-016-2457-9] [PMID: 27957699]
[14]
Sheng B, Truong K, Spitler H, Zhang L, Tong X, Chen L. The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis. Obes Surg 2017; 27(10): 2724-32.
[http://dx.doi.org/10.1007/s11695-017-2866-4] [PMID: 28801703]
[15]
Costa AMF, et al. Carga do diabetes mellitus tipo 2 no Brasil. Cad Saúde Pública 2017; 33(2): 1-14.
[16]
Brasil Ministério da Saúde Secretaria de Atenção À Saúde Departamento de Atenção Básica Política Nacional de Atenção Básica / Ministério da Saúde, Secretaria de Atenção à Saúde, Departamento de Atenção Básica. Brasília: Ministério da Saúde 2019.
[17]
Canivell S, Gomis R. Diagnosis and classification of autoimmune diabetes mellitus. Autoimmun Rev 2014; 13(4-5): 403-7.
[http://dx.doi.org/10.1016/j.autrev.2014.01.020] [PMID: 24424179]
[18]
Galtier F. Definition, epidemiology, risk factors. Diabetes Metab 2010; 36(6 Pt 2): 628-51.
[http://dx.doi.org/10.1016/j.diabet.2010.11.014] [PMID: 21163426]
[19]
Hussain S, Chowdhury TA. The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus. Drugs 2019; 79(3): 231-42.
[http://dx.doi.org/10.1007/s40265-019-1061-4] [PMID: 30742277]
[20]
Martinez LC, Sherling D, Holley A. The Screening and Prevention of Diabetes Mellitus. Prim Care 2019; 46(1): 41-52.
[http://dx.doi.org/10.1016/j.pop.2018.10.006] [PMID: 30704659]
[21]
Massey CN, Feig EH, Duque-Serrano L, Wexler D, Moskowitz JT, Huffman JC. Well-being interventions for individuals with diabetes: A systematic review. Diabetes Res Clin Pract 2019; 147: 118-33.
[http://dx.doi.org/10.1016/j.diabres.2018.11.014] [PMID: 30500545]
[22]
Shah SR, Iqbal SM, Alweis R, Roark S. A closer look at heart failure in patients with concurrent diabetes mellitus using glucose lowering drugs. Expert Rev Clin Pharmacol 2019; 12(1): 45-52.
[http://dx.doi.org/10.1080/17512433.2019.1552830] [PMID: 30488734]
[23]
Chinese Diabetes SocietyNational Office for Primary Diabetes Care. National guidelines for the prevention and control of diabetes in primary care. Zhonghua Nei Ke Za Zhi 2018; 57(12): 885-93.
[PMID: 30486556]
[24]
Su YJ, Chen TH, Hsu CY, Chiu WT, Lin YS, Chi CC. Safety of Metformin in Psoriasis Patients With Diabetes Mellitus: A 17-Year Population-Based Real-World Cohort Study. J Clin Endocrinol Metab 2019; 104(8): 3279-86.
[http://dx.doi.org/10.1210/jc.2018-02526] [PMID: 30779846]
[25]
Einstein A. Sociedade Beneficente Israelita Brasileira 2014.http://portal.anvisa.gov.br/wps/wcm/connect/4eff8d8041811939959bf722d1e56fc9/-+3-%2BSoc.Ben.Israelita%2BBras.pdf?MOD=AJPERES
[26]
Oliveira JEP, Milech A, Eds. Diabetes mellitus: clínica, diagnóstico e tratamento multidisciplinar. São Paulo: Atheneu 2014.
[27]
Choi SE, Berkowitz SA, Yudkin JS, Naci H, Basu S. Personalizing Second-Line Type 2 Diabetes Treatment Selection: Combining Network Meta-analysis, Individualized Risk, and Patient Preferences for Unified Decision Support. Med Decis Making 2019; 39(3): 239-52.
[http://dx.doi.org/10.1177/0272989X19829735] [PMID: 30767632]
[28]
Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg 2013; 23(1): 93-102.
[http://dx.doi.org/10.1007/s11695-012-0802-1] [PMID: 23161525]
[29]
Willis M, Asseburg C, Neslusan C. Conducting and interpreting results of network meta-analyses in type 2 diabetes mellitus: A review of network meta-analyses that include sodium glucose co- transporter 2 inhibitors. Diabetes Res Clin Pract 2019; 148: 222-33.
[http://dx.doi.org/10.1016/j.diabres.2019.01.005] [PMID: 30641163]
[30]
Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011; 54(10): 2506-14.
[http://dx.doi.org/10.1007/s00125-011-2204-7] [PMID: 21656330]
[31]
Bertonhi LG, Dias JCR. Diabetes mellitus tipo 2: aspectos clínicos, tratamento e conduta dietoterápica. Revista Ciências Nutricionais Online 2018; 2(2): 1-10.
[32]
Neto PRO, Guidone CM. Dispensação de medicamentos no Diabetes Mellitus Curso de Capacitação em Dispensação de Medicamentos Módulo IV. Faculdade de Ciências Farmacêuticas de Ribeirão Preto. Universidade de São Paulo 2015.
[33]
Lai LL, Wan Yusoff WNI, Vethakkan SR, Nik Mustapha NR, Mahadeva S, Chan WK. Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography. J Gastroenterol Hepatol 2019; 34(8): 1396-403.
[PMID: 30551263]
[34]
Eckstein ML, Williams DM, O’Neil LK, Hayes J, Stephens JW, Bracken RM. Physical exercise and non-insulin glucose-lowering therapies in the management of Type 2 diabetes mellitus: a clinical review. Diabet Med 2019; 36(3): 349-58.
[PMID: 30536728]
[35]
Thewjitcharoen Y, Chotwanvirat P, Jantawan A, et al. Evaluation of Dietary Intakes and Nutritional Knowledge in Thai Patients with Type 2 Diabetes Mellitus. J Diabetes Res 2018; 2018: 9152910.
[http://dx.doi.org/10.1155/2018/9152910] [PMID: 30671482]
[36]
Kempegowda P, Chandan JS, Abdulrahman S, Chauhan A, Saeed MA. Managing hypertension in people of African origin with diabetes: Evaluation of adherence to NICE Guidelines. Prim Care Diabetes 2019; 13(3): 266-71.
[http://dx.doi.org/10.1016/j.pcd.2018.12.007] [PMID: 30704854]
[37]
Carrillo-Larco RM, Barengo NC, Albitres-Flores L, Bernabe-Ortiz A. The risk of mortality among people with type 2 diabetes in Latin America: A systematic review and meta-analysis of population-based cohort studies. Diabetes Metab Res Rev 2019; 35(4): e3139.
[http://dx.doi.org/10.1002/dmrr.3139] [PMID: 30761721]
[38]
Girund MG. Remissão do Diabetes Mellitus Tipo 2 dezoito meses após gastroplastia com derivação em Y-de-Roux. Rev Col Bras Cir 2016; 43(3): 149-53.
[PMID: 27556537]
[39]
Coelho D, Godoy EP, Marreiros I, Luz VF, Campos JM. Taxa de remissão do diabete em diferentes IMCS após bypass gástrico em y-de-roux. ABCD Arq Bras Cir Dig 2018; 31(1): e1343.
[http://dx.doi.org/10.1590/0102-672020180001e1343] [PMID: 29513804]
[40]
Stone MA, Camosso-Stefinovic J, Wilkinson J, de Lusignan S, Hattersley AT, Khunti K. Incorrect and incomplete coding and classification of diabetes: a systematic review. Diabet Med 2010; 27(5): 491-7.
[http://dx.doi.org/10.1111/j.1464-5491.2009.02920.x] [PMID: 20536944]
[41]
Boza C, Muñoz R, Salinas J, et al. Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients. Obes Surg 2011; 21(9): 1330-6. [Internet].
[http://dx.doi.org/10.1007/s11695-011-0463-5] [PMID: 21744283]
[42]
Cakan N, Kizilbash S, Kamat D. Changing spectrum of diabetes mellitus in children: challenges with initial classification. Clin Pediatr (Phila) 2012; 51(10): 939-44.
[http://dx.doi.org/10.1177/0009922812441666] [PMID: 22496179]
[43]
Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2010; 6(3): 254-9. [Internet].
[http://dx.doi.org/10.1016/j.soard.2009.11.003] [PMID: 20303324]
[44]
Mechanick JI, Youdim A, Jones DB, et al. American Association of Clinical Endocrinologists; Obesity Society; American Society for Metabolic & Bariatric Surgery. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery. Endocr Pract 2013; 19(2): 337-72.
[http://dx.doi.org/10.4158/EP12437.GL] [PMID: 23529351]
[45]
Velem F, Stroparo E. Possível remissão do diabetes mellitus tipo 2 em relação a redução da gordura visceral. Revista Eletrônica Biociências, Biotecnologia e Saúde 2018; 20: 32-6.
[46]
Brasil.. Ministério da Saúde. Resolução n. 2.172 de 22 de novembro de 2017 do Conselho Federal de Medicina (CFM). Reconhece a cirurgia metabólica para o tratamento de pacientes portadores de diabetes mellitus tipo 2, com IMC entre 30 kg/m2 e 34,9 kg/m2, sem resposta ao tratamento clínico convencional, como técnica não experimental de alto risco e complexidade 2017.
[47]
Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci 2014; 11(11): 1185-200.
[http://dx.doi.org/10.7150/ijms.10001] [PMID: 25249787]
[48]
Josemberg Campos J, Ramos A, Szego T, Zilberstein B, Feitosa H, Cohen R. O papel da cirurgia metabólica para tratamento de pacientes com obesidade grau I e diabete tipo 2 não controlados clinicamente. ABCD Arq Bras Cir Dig 2016; 29(Suppl. 1): 102-6.
[49]
Bradley D, Conte C, Mittendorfer B, et al. Gastric bypass and banding equally improve insulin sensitivity and β cell function. J Clin Invest 2012; 122(12): 4667-74.
[http://dx.doi.org/10.1172/JCI64895] [PMID: 23187122]
[50]
Rubino F, Nathan DM, Eckel RH, et al. Delegates of the 2nd Diabetes Surgery Summit. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care 2016; 39(6): 861-77.
[http://dx.doi.org/10.2337/dc16-0236] [PMID: 27222544]
[51]
Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 2012; 367(8): 695-704.
[http://dx.doi.org/10.1056/NEJMoa1112082] [PMID: 22913680]
[52]
Madsen Lene R, et al. Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study. Diabetologia 2019.
[http://dx.doi.org/10.1007/s00125-019-4816-2]
[53]
Schauer PR, Mingrone G, Ikramuddin S, Wolfe B. Clinical outcomes of metabolic surgery: efficacy of glycemic control, weight loss, and remission of diabetes. Diabetes Care 2016; 39(6): 902-11.
[http://dx.doi.org/10.2337/dc16-0382] [PMID: 27222548]
[54]
Lakdawala M, Shaikh S, Bandukwala S, Remedios C, Shah M, Bhasker AG. Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30-35 kg/m(2)) Indian patients with type 2 diabetes mellitus. Surg Obes Relat Dis 2013; 9(3): 370-8.
[http://dx.doi.org/10.1016/j.soard.2012.07.017] [PMID: 23068107]
[55]
Panunzi S, Carlsson L, De Gaetano A, et al. Determinants of diabetes remission and glycemic control after bariatric surgery. Diabetes Care 2016; 39(1): 166-74.
[http://dx.doi.org/10.2337/dc15-0575] [PMID: 26628418]
[56]
Cohen RV, Pinheiro JC, Schiavon CA, Salles JE, Wajchenberg BL, Cummings DE. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012; 35(7): 1420-8.
[http://dx.doi.org/10.2337/dc11-2289] [PMID: 22723580]
[57]
Hsu CC, Almulaifi A, Chen JC, et al. Effect of Bariatric Surgery vs Medical Treatment on Type 2 Diabetes in Patients With Body Mass Index Lower Than 35: Five-Year Outcomes. JAMA Surg 2015; 150(12): 1117-24.
[http://dx.doi.org/10.1001/jamasurg.2015.2602] [PMID: 26374954]
[58]
Ikramuddin S, Korner J, Lee WJ, et al. Durability of addition of Roux-en-Y gastric bypass to lifestyle intervention and medical management in achieving primary treatment goals for uncontrolled type 2 diabetes in mild to moderate obesity: a randomized control trial. Diabetes Care 2016; 39(9): 1510-8.
[http://dx.doi.org/10.2337/dc15-2481] [PMID: 27311493]
[59]
Gross J, et al. Diagnostico, classificação e avaliação do controle glicêmico. Arq Bras Endocrinol 2016; 46(1)
[60]
Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non- surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 347: f5934.
[http://dx.doi.org/10.1136/bmj.f5934] [PMID: 24149519]
[61]
Schauer PR, Bhatt DL, Kirwan JP, et al. STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014; 370(21): 2002-13.
[http://dx.doi.org/10.1056/NEJMoa1401329] [PMID: 24679060]
[62]
Müller-Stich BP, Senft JD, Warschkow R, et al. Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis. Ann Surg 2015; 261(3): 421-9.
[http://dx.doi.org/10.1097/SLA.0000000000001014] [PMID: 25405560]
[63]
Cho YM. A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgery. Diabetes Metab J 2014; 38(6): 406-15.
[http://dx.doi.org/10.4093/dmj.2014.38.6.406] [PMID: 25541603]
[64]
Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 2011; 146(2): 143-8.
[http://dx.doi.org/10.1001/archsurg.2010.326] [PMID: 21339423]
[65]
Shah PS, Todkar JS, Shah SS. Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis 2010; 6(2): 138-41.
[http://dx.doi.org/10.1016/j.soard.2009.06.007] [PMID: 19733515]
[66]
Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery 2010; 147(5): 664-9.
[http://dx.doi.org/10.1016/j.surg.2009.10.059] [PMID: 20004451]
[67]
Lee WJ, Hur KY, Lakadawala M, Kasama K, Wong SK, Lee YC. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. J Gastrointest Surg 2012; 16(1): 45-51.
[http://dx.doi.org/10.1007/s11605-011-1740-2] [PMID: 22042564]
[68]
Liu SY, Wong SK, Lam CC, Yung MY, Kong AP, Ng EK. Long-term results on weight loss and diabetes remission after laparoscopic sleeve gastrectomy for a morbidly obese Chinese population. Obes Surg 2015; 25(10): 1901-8.
[http://dx.doi.org/10.1007/s11695-015-1628-4] [PMID: 25761944]
[69]
Park JY, Kim YJ. Efficacy of laparoscopic sleeve gastrectomy in mildly obese patients with body mass index of 30-35 kg/m (2). Obes Surg 2015; 25(8): 1351-7.
[http://dx.doi.org/10.1007/s11695-015-1575-0] [PMID: 25656261]
[70]
Todkar JS, Shah SS, Shah PS, Gangwani J. Long-term effects of laparoscopic sleeve gastrectomy in morbidly obese subjects with type 2 diabetes mellitus. Surg Obes Relat Dis 2010; 6(2): 142-5.
[http://dx.doi.org/10.1016/j.soard.2009.06.008] [PMID: 19733513]
[71]
Lee WJ, Chong K, Lin YH, Wei JH, Chen SC. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg 2014; 24(9): 1552-62.
[http://dx.doi.org/10.1007/s11695-014-1344-5] [PMID: 24965545]
[72]
Zhang Y, Zhao H, Cao Z, et al. A randomized clinical trial of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy for the treatment of morbid obesity in China: a 5-year outcome. Obes Surg 2014; 24(10): 1617-24.
[http://dx.doi.org/10.1007/s11695-014-1258-2] [PMID: 24827405]
[73]
Kular KS, Manchanda N, Rutledge R. Analysis of the five-year outcomes of sleeve gastrectomy and mini gastric bypass: a report from the Indian sub-continent. Obes Surg 2014; 24(10): 1724-8.
[http://dx.doi.org/10.1007/s11695-014-1264-4] [PMID: 24805912]
[74]
Panunzi S, De Gaetano A, Carnicelli A, Mingrone G. Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis. Ann Surg 2015; 261(3): 459-67.
[http://dx.doi.org/10.1097/SLA.0000000000000863] [PMID: 25361217]
[75]
Pories WJ, Dohm LG, Mansfield CJ. Beyond the BMI: the search for better guidelines for bariatric surgery. Obesity (Silver Spring) 2010; 18(5): 865-71.
[http://dx.doi.org/10.1038/oby.2010.8] [PMID: 20150899]
[76]
Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 2015; 386(9997): 964-73.
[http://dx.doi.org/10.1016/S0140-6736(15)00075-6] [PMID: 26369473]
[77]
Wong SK, Kong AP, So WY, et al. Use of laparoscopic sleeve gastrectomy and adjustable gastric banding for suboptimally controlled diabetes in Hong Kong. Diabetes Obes Metab 2012; 14(4): 372-4.
[http://dx.doi.org/10.1111/j.1463-1326.2011.01528.x] [PMID: 22050632]
[78]
Kim Z, Hur KY. Laparoscopic mini-gastric bypass for type 2 diabetes: the preliminary report. World J Surg 2011; 35(3): 631-6.
[http://dx.doi.org/10.1007/s00268-010-0909-2] [PMID: 21165621]
[79]
Shah SS, Todkar JS, Shah PS, Cummings DE. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2). Surg Obes Relat Dis 2010; 6(4): 332-8.
[http://dx.doi.org/10.1016/j.soard.2009.08.009] [PMID: 19846351]
[80]
Malapan K, Goel R, Tai CM, Kao YH, Chang PC, Huang CK. Laparoscopic Roux-en-Y gastric bypass for nonobese type II diabetes mellitus in Asian patients. Surg Obes Relat Dis 2014; 10(5): 834-40.
[http://dx.doi.org/10.1016/j.soard.2014.01.018] [PMID: 24857051]
[81]
Singh AK, Singh R, Kota SK. Bariatric surgery and diabetes remission: Who would have thought it? Indian J Endocrinol Metab 2015; 19(5): 563-76.
[http://dx.doi.org/10.4103/2230-8210.163113] [PMID: 26425464]
[82]
Liang H, Guan W, Yang Y, et al. Roux-en-Y gastric bypass for Chinese type 2 diabetes mellitus patients with a BMI < 28 kg/m(2): a multi-institutional study. J Biomed Res 2015; 29(2): 112-7.
[PMID: 25859265]
[83]
Lee HC, Kim MK, Kwon HS, Kim E, Song KH. Early changes in incretin secretion after laparoscopic duodenal-jejunal bypass surgery in type 2 diabetic patients. Obes Surg 2010; 20(11): 1530-5.
[http://dx.doi.org/10.1007/s11695-010-0248-2] [PMID: 20803098]
[84]
Benotti P, Wood GC, Winegar DA, et al. Risk factors associated with mortality after Roux-en-Y gastric bypass surgery. Ann Surg 2014; 259(1): 123-30.
[http://dx.doi.org/10.1097/SLA.0b013e31828a0ee4] [PMID: 23470583]
[85]
Lee WJ, Lee KT, Kasama K, et al. Laparoscopic single-anastomosis duodenal-jejunal bypass with sleeve gastrectomy (SADJB-SG): short-term result and comparison with gastric bypass. Obes Surg 2014; 24(1): 109-13.
[http://dx.doi.org/10.1007/s11695-013-1067-z] [PMID: 23990452]
[86]
Lee WJ, Almulaifi AM, Tsou JJ, Ser KH, Lee YC, Chen SC. Duodenal-jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion. Surg Obes Relat Dis 2015; 11(4): 765-70.
[http://dx.doi.org/10.1016/j.soard.2014.12.017] [PMID: 25813754]
[87]
Bojsen-Møller KN, Dirksen C, Jørgensen NB, et al. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass. Diabetes 2014; 63(5): 1725-37.
[http://dx.doi.org/10.2337/db13-1307] [PMID: 24241533]
[88]
Seki Y, Kasama K, Umezawa A, Kurokawa Y. Laparoscopic sleeve gastrectomy with duodenojejunal bypass for type 2 diabetes mellitus. Obes Surg 2016; 26(9): 2035-44.
[http://dx.doi.org/10.1007/s11695-016-2057-8] [PMID: 26749411]
[89]
Palikhe G, Gupta R, Behera BN, Sachdeva N, Gangadhar P, Bhansali A. Efficacy of laparoscopic sleeve gastrectomy and intensive medical management in obese patients with type 2 diabetes mellitus. Obes Surg 2014; 24(4): 529-35.
[http://dx.doi.org/10.1007/s11695-013-1114-9] [PMID: 24272885]
[90]
Santiago-Fernández C, García-Serrano S, Tome M, et al. Ghrelin levels could be involved in the improvement of insulin resistance after bariatric surgery. Endocrinol Diabetes Nutr 2017; 64(7): 355-62.
[http://dx.doi.org/10.1016/j.endinu.2017.05.002] [PMID: 28745606]
[91]
Liang Ziwen, et al. Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes research and clinical practice 2013.
[http://dx.doi.org/10.1016/j.diabres.2013.04.005]
[92]
Seki Y, Kasama K, Haruta H, et al. Five-Year-Results of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass for Weight Loss and Type 2 Diabetes Mellitus. Obes Surg 2017; 27(3): 795-801.
[http://dx.doi.org/10.1007/s11695-016-2372-0] [PMID: 27644433]
[93]
Rao WS, Shan CX, Zhang W, Jiang DZ, Qiu M. A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI ≤ 35 kg/m2 undergoing Roux-en-Y gastric bypass. World J Surg 2015; 39(1): 223-30.
[http://dx.doi.org/10.1007/s00268-014-2751-4] [PMID: 25159119]
[94]
Khorgami Z, Shoar S, Saber AA, Howard CA, Danaei G, Sclabas GM. Outcomes of bariatric surgery versus medical management for type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Obes Surg 2019; 29(3): 964-74.
[http://dx.doi.org/10.1007/s11695-018-3552-x] [PMID: 30402804]
[95]
Rubio-Almanza M, Hervás-Marín D, Cámara-Gómez R, Caudet-Esteban J, Merino-Torres JF. Does Metabolic Surgery Lead to Diabetes Remission in Patients with BMI < 30 kg/m2?: a Meta-analysis. Obes Surg 2019; 29(4): 1105-16.
[http://dx.doi.org/10.1007/s11695-018-03654-x] [PMID: 30604080]
[96]
Heo YS, Park JM, Kim YJ, et al. Bariatric surgery versus conventional therapy in obese Korea patients: a multicenter retrospective cohort study. J Korean Surg Soc 2012; 83(6): 335-42.
[http://dx.doi.org/10.4174/jkss.2012.83.6.335] [PMID: 23230551]
[97]
Praveen Raj P, Bhattacharya S, Saravana Kumar S, et al. Do Bariatric Surgery-Related Type 2 Diabetes Remission Predictors Add Clinical Value? A Study on Asian Indian Obese Diabetics. Obes Surg 2017; 27(8): 2113-9.
[http://dx.doi.org/10.1007/s11695-017-2615-8] [PMID: 28236254]
[98]
Aminian Ali, et al. A nationwide safety analysis of bariatric surgery in nonseverely obese patients with type 2 diabetes. Surgery for Obesity and Related Diseases 2016.
[http://dx.doi.org/10.1016/j.soard.2016.05.007]
[99]
Angrisani Luigi, Lorenzo Michele, Borrelli Vincenzo. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surgery for obesity and related diseases 2007.
[100]
Daigle CR, Brethauer SA, Tu C, et al. Which postoperative complications matter most after bariatric surgery? Prioritizing quality improvement efforts to improve national outcomes. Surg Obes Relat Dis 2018; 14(5): 652-7.
[http://dx.doi.org/10.1016/j.soard.2018.01.008] [PMID: 29503096]
[101]
Corbeels K, Verlinden L, Lannoo M, et al. Thin bones: Vitamin D and calcium handling after bariatric surgery. Bone Rep 2018; 8: 57-63.
[http://dx.doi.org/10.1016/j.bonr.2018.02.002] [PMID: 29955623]
[102]
Rubino F, Amiel SA. Is the gut the “sweet spot” for the treatment of diabetes? Diabetes 2014; 63(7): 2225-8.
[http://dx.doi.org/10.2337/db14-0402] [PMID: 24962924]
[103]
Hedenbro JL, Näslund E, Boman L, et al. Formation of the Scandinavian Obesity Surgery Registry, SOReg. Obes Surg 2015; 25(10): 1893-900.
[http://dx.doi.org/10.1007/s11695-015-1619-5] [PMID: 25703826]
[104]
Min T, Barry JD, Stephens JW. Predicting the Resolution of Type 2 Diabetes after Bariatric Surgical Procedures: A Concise Review. J Diabetes Metab 2015; 6: 1-5.
[105]
Alam U, Asghar O, Azmi S, Malik RA. General aspects of diabetes mellitus. Handb Clin Neurol 2014; 126: 211-22.
[http://dx.doi.org/10.1016/B978-0-444-53480-4.00015-1] [PMID: 25410224]
[106]
Jans A, Näslund I, Ottosson J, Szabo E, Näslund E, Stenberg E. Duration of type 2 diabetes and remission rates after bariatric surgery in Sweden 2007-2015: A registry-based cohort study. PLoS Med 2019; 16(11): e1002985.
[http://dx.doi.org/10.1371/journal.pmed.1002985] [PMID: 31747392]
[107]
Rubino F, Nathan DM, Eckel RH, et al. Delegates of the 2nd Diabetes Surgery Summit. Delegates of the 2nd Diabetes Surgery Summit. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care 2016; 39(6): 861-77.
[http://dx.doi.org/10.2337/dc16-0236] [PMID: 27222544]
[108]
Salinari S, Debard C, Bertuzzi A, et al. Jejunal proteins secreted by db/db mice or insulin-resistant humans impair the insulin signaling and determine insulin resistance. PLoS One 2013; 8(2): e56258.
[http://dx.doi.org/10.1371/journal.pone.0056258] [PMID: 23437106]
[109]
Campos J, Ramos A, Szego T, Zilberstein B, Feitosa H, Cohen R. The role of metabolic surgery for patients with obesity grade I and type 2 diabetes not controlled clinically. Arq Bras Cir Dig 2016; 29(Suppl. 1): 102-6.
[http://dx.doi.org/10.1590/0102-6720201600s10025] [PMID: 27409057]
[110]
Busetto L, Dixon J, De Luca M, Shikora S, Pories W, Angrisani L. Bariatric surgery in class I obesity : a Position Statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg 2014; 24(4): 487-519.
[http://dx.doi.org/10.1007/s11695-014-1214-1] [PMID: 24638958]
[111]
Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 2010; 59(12): 3049-57.
[http://dx.doi.org/10.2337/db10-0253] [PMID: 20876719]
[112]
Sjöholm K, Anveden A, Peltonen M, et al. Evaluation of current eligibility criteria for bariatric surgery: diabetes prevention and risk factor changes in the Swedish obese subjects (SOS) study. Diabetes Care 2013; 36(5): 1335-40.
[http://dx.doi.org/10.2337/dc12-1395] [PMID: 23359358]
[113]
Huang X, Liu T, Zhong M, Cheng Y, Hu S, Liu S. Predictors of glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass: A meta-analysis, meta-regression, and systematic review. Surg Obes Relat Dis 2018; 14(12): 1822-31.
[http://dx.doi.org/10.1016/j.soard.2018.08.027] [PMID: 30385071]
[114]
Ahuja A, Tantia O, Chaudhuri T, et al. Predicting remission of diabetes post metabolic surgery: a comparison of ABCD, diarem, and DRS scores. Obes Surg 2018; 28(7): 2025-31.
[http://dx.doi.org/10.1007/s11695-018-3136-9] [PMID: 29435812]